Global 3D Bioprinting Market by Application (Dental, Biosensors, Medical, Bioinks), by Technology (Inkjet-based, Magnetic Levitation) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global 3D bioprinting market was valued at USD1.4 billion in 2020. It is projected to grow at a compound annual rate (CAGR), of 15.8% between 2021 and 2028. This market's growth is due to a small number of organ donors and an aging population with chronic respiratory illnesses. Other important factors that will drive market growth are technological advancements, rising R&D investment and an increasing incidence of chronic disease.

Even developed countries are seeing their healthcare systems overburdened and fatigued as a result of the coronavirus pandemic that has recently swept the globe. As a result, many 3D Bioprinting groups are offering their expertise to help ease the burden on supply chains and governments.

There has been a shortage in materials both for medical professionals and the general public as COVID-19 cases are on the rise. The lack of COVID-19 test kits is one of the most serious problems. Many 3D bioprinting companies produce 3D printers on a large scale. Formlabs, a Massachusetts-based company, is currently manufacturing 100,000 nasal swabs each day for COVID-19 testing. The increasing number of COVID-19 cases is driving the demand for 3D printers. This market is expected to grow exponentially.

Impact of COVID19: Expected to see a 14.5% growth rate after 2020

Scientists are now using new technology to safety-test patients following completion of preclinical trials. This has also helped accelerate the development and testing of vaccine and drug testing. Medical professionals are also experiencing a shortage in ventilators and respirators due to COVID-19. To overcome this shortage, 3D bioprinting technology has been used to manufacture ventilators and respirators.

CLECELL, a 3D printing company, recently created a model of the respiratory epithelium using their 3D printer UFAB and other bioprinting technologies. The majority of the respiratory tract is lined by the epithelium, which is a type tissue. The epithelium serves as a barrier against foreign particles and pathogens. It also protects tissue from infection and injury thanks to the mucociliary lift. The market for 3D bioprinting will grow as there is more demand for the respiratory epithelium model. This innovation is expected to drive market growth during the forecast period.

Biotherapeutic companies use 3D bioprinting technology to speed up COVID-19 research. Viscient Biosciences, for example, used 3D bioprinting technology in order to create lung tissue. This supports viral infection research and aids in the search for an effective treatment against SARS-CoV-2 (the novel coronavirus that causes COVID-19). In collaboration with other research institutes, the Wyss Institute at Harvard University designed a fully-injection-molded nasopharyngeal scrub.

With the growing popularity of Covid-19, 3D bioprinting has been in high demand. Many pharmaceutical and biopharmaceutical companies are now ready to assist healthcare workers, doctors, and scientists in any way they can. Stratasys, one of America's leading 3D printer manufacturers, has produced face shields using a 3D bioprinter. They shipped 100,000 face shields to the U.S. up until March 2020.

Technology Insights

Inkjet-based 3D bioprinting was the dominant segment. It accounted for 36.0% of the total market share in 2020. This is because it allows the printing complex living organs and tissues onto culture substrates using biomaterials such as bio-inks. This is due to the widespread adoption of inkjet printing in medicine. This paper presents research trends in inkjet printers as a bio-applicable technology, particularly in the areas of tissue engineering and drug delivery. Due to its higher reliability and increasing demand, this segment will see significant growth in the future.

Magnetic levitation is expected to grow at a 17.0% CAGR over the forecast period. This technology's cost efficiency is responsible for the lucrative growth. With its superior features, speed and precision, magnetic levitation technology will solve over 80.0% of 3D bioprinting errors. These bioprinters can also be used for toxicity screening, vascular muscles printing, and human cell renewal. BioAssay, for instance, has created a tissue-like structure using magnetic levitation-based technology. Due to rapid growth of newer technologies, magnetic levitation-based devices will likely experience slow growth.

Application Type Insights

3D bioprinting was a market dominated by the medical sector, which accounted for 36.2% of the total revenue in 2020. This segment is expected to grow at a CAGR 19.0% during the forecast period. The market for 3D bioprinting is seeing a lot of people use medical pills to treat various chronic diseases. The segment is also driven by the rising demand for medicines and the efficient application of bio-drugs with this technology. The demand for medical pills is growing due to the increasing participation of pharmaceutical companies. Globally, millions of people use capsules and other medicinal pills regularly. This segment is expected to experience lucrative growth during the forecast period.

The market for 3D-bioprinting will see the highest CAGR at 19.3% over the forecast period. This is the tissue and organ generation segment. 3D bioprinting is used most commonly to create transplantable tissue and organs. The demand for organ and tissue generation is growing due to the increasing incidence of COVID-19. The tissue and organ generation market is forecast to experience exponential growth during the forecast period. Globally, the increasing incidence of COVID-19 is expected to open up new opportunities for market leaders. Diverse players are working together to develop new technologies that can overcome the pandemic effect of COVID-19 and create a vaccine.

Regional Insights

North America was the dominant market for 3D bioprinting in 2020, accounting for 32.4% of the total revenue. Market growth will be stimulated by the increasing use of IT in healthcare. According to the World Meter Report 2021 there were approximately 23,369,732 cases of Covid-19 in the United States alone between January 13th 2021 and January 13th 2021. There are more than 50 vaccine candidates currently under investigation. To develop a vaccine, the government is investing more in research and development. This is why there is a growing demand for 3D Bioprinting, as this technology has been rediscovered for drug testing and transplantation.

Asia Pacific accounted for 23.4% of the region's revenue in 2020. This market is expected to maintain its dominance during the forecast period. Japan and China held the largest revenue shares in the region, due to increasing COVID-19 incidence and rising government investment in R&D. The market will be further driven by the increasing mortality rate from COVID-19, and the scarcity of organ donors.

Market Share Insights & Key Companies

To gain an edge in the market, key companies have been focusing on research and development to create technologically advanced applications. CELLINK, for instance, has developed Bio X6 a 3D bioprinting device and Lumen X, which creates vascular structures. Fluicell Sweden, a company based in Sweden, has also launched Biopixlar, a high-resolution 3D and 2-D bioprinting technology. The 3D bioprinter can create complex tissue-like structures that allow for the control of cell positioning. The system is controlled by a unique feature.

In order to increase their application portfolios and manufacturing capabilities, companies are now engaging in mergers and acquisitions. This helps them differentiate themselves and allows them to form partnerships. In November 2019, BASF GmbH bought Sculpteo, a provider of 3D printing services. This acquisition will allow BASF to quickly market and establish industrial 3D printing materials. The following are some of the most prominent players in 3D bioprinting:

• Envisiontec, Inc.

• Organovo Holdings, Inc.

• Inventia Life Science PTY Ltd

• Poietis

• Vivax Bio, LLC

• Allevi

• Cyfuse Biomedical K.K.

• 3D Bioprinting Solutions

• Cellink Global

• Regemat 3D S.L.

Up Market Research published a new report titled “3D Bioprinting Market research report which is segmented by Application (Dental, Biosensors, Medical, Bioinks), by Technology (Inkjet-based, Magnetic Levitation), By Players/Companies Allevi, Envisiontec Inc, Cellink Global, Poietis, Organovo Holdings Inc, 3D Bioprinting Solutions, Vivax Bio LLC, Inventia Life Science PTY LTD, Regemat 3D SL, Cyfuse Biomedical KK”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global 3D Bioprinting Market Report Segments:

The market is segmented by Application (Dental, Biosensors, Medical, Bioinks), by Technology (Inkjet-based, Magnetic Levitation).

3D Bioprinting Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the 3D Bioprinting Market

Overview of the regional outlook of the 3D Bioprinting Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The 3D Bioprinting Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of 3D Bioprinting Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Dental

                2. Biosensors

                3. Medical

                4. Bioinks

                1. Inkjet-based

                2. Magnetic Levitation

8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the 3D Bioprinting Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the 3D Bioprinting Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.